Annals of Hematology

, Volume 71, Issue 4, pp 185–187 | Cite as

Hemoglobin variants recently detected in Austria

  • W. J. Schnedl
  • E. C. Reisinger
  • R. W. Lipp
  • P. Hopmeier
  • G. J. Krejs
Original Article


Measurement of glycated hemoglobin (HbA1c) is used for routine management of diabetic patients. Glucose linkage to HbA1c reflects mean blood glucose levels during the last 3 months before examination. Various methods for HbA1c determination show abnormal values with hemoglobin variants. In some diabetic patients excessively high HbA1c values with high-performance liquid chromatography (HPLC) led to the detection of Hb Graz. In addition to Hb Graz, other silent hemoglobin variants have been found in Austria. Here we review Hb Graz, Hb Sherwood Forest, and Hb Okayama detected while using HPLC for the measurement of HbA1c in diabetic patients.

Key words

Glycated hemoglobin HbA1c Hemoglobinopathy β-chain mutation High-performance liquid chromatography Hb Graz Hb Sherwood Forest Hb Okayama 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Armbruster DA (1978) Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 33:2153–2163Google Scholar
  2. 2.
    Bisse E, Wieland H (1988) High-performance liquid Chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins. J Chromatogr 434:95–110PubMedGoogle Scholar
  3. 3.
    Braunsteiner H, Dienstl F, Sailer S, Sandhofer F (1964) Angeborene hämolytische Anämie mit Mesobilifuscinurie und Innenkörperbildung nach Splenectomie. Acta Haematol 32:314–320PubMedGoogle Scholar
  4. 4.
    Delahunty T (1990) Convenient screening for hemoglobin variants by using the Diamat HPLC system. Clin Chem 36:903–905PubMedGoogle Scholar
  5. 5.
    Editorial (1994) International Hemoglobin Information Center variant list. Hemoglobin 18:77–183Google Scholar
  6. 6.
    Francesconi M, Hopmeier P, Huisman THJ (1993) A diabetic patient with a glycohemoglobin of 47% [Abstract]. Diabetologia 36 (Suppl 1):A159Google Scholar
  7. 7.
    Goldstein DE, Little RR, Wiedmeyer HM, England JD, Rohlfing CL, Wilke AL (1994) Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the Diabetes Control and Complications Trial. Clin Chem 40:1637–1640PubMedGoogle Scholar
  8. 8.
    Harano T, Harano K, Shibata S, Ueda S, Mori H, Arimasa N (1983) Hemoglobin Okayama [β2(NA2)His→Gln]: a new silent hemoglobin variant with substituted amino acid residue at the 2,3-diphosphoglycerate binding site. FEBS Lett 156:20–22PubMedGoogle Scholar
  9. 9.
    Harano T, Harano K, Ueda S, Imai K, Ohkuma A, Koya Y, Takahashi H (1990) Hb Fukuoka [β2(NA2)His→Tyr]: a new mutation at the 2,3-diphosphoglycerate binding site. Hemoglobin 14:199–205PubMedGoogle Scholar
  10. 10.
    Labossiere A, Vella F, Hiebert J, Galbraith P (1972) Hemoglobin Deer Lodge: α2β22His→Arg. Clin Biochem 5:46–50PubMedGoogle Scholar
  11. 11.
    Langdown JV, Davidson RJ, Williamson D (1992) A new alpha chain variant, Hb Turriff [alpha 99 (G6) Lys-Glu]: the interference of abnormal hemoglobins in HbA 1c determination. Hemoglobin 16:11–17PubMedGoogle Scholar
  12. 12.
    Liu JS, Molchanova TP, Gu LH, Wilson JB, Hopmeier P, Schnedl W, Balaun E, Krejs GJ, Huisman THJ (1992) Hb-Graz or α2β22(NA2)His-Leu; a newβ chain variant observed in four families from southern Austria. Hemoglobin 16:493–501PubMedGoogle Scholar
  13. 13.
    Lorkin PA, Pietschmann H, Braunsteiner H, Lehmann H (1974) Structure of haemoglobin Wien β130(H8) tyrosine → aspartic acid: an unstable haemoglobin variant. Acta Haematol 51:351–361PubMedGoogle Scholar
  14. 14.
    Maezawa Y, Yamauchi M, Nakabayashi T, Toshima K, Ikeda K. Toda G (1993) A diabetic case of Hb Riyadh with low HbA1c value. Intern Med 32:128–132PubMedGoogle Scholar
  15. 15.
    Marrero DG, Vandagriff JL, Gibson R, Fineberg SE, Fineberg NS, Hiar CE, Crowley LE (1992) Immediate HbAlc results. Performance of new HbA1c system in pediatric outpatient population. Diabetes Care 15:1045–1049PubMedGoogle Scholar
  16. 16.
    Robertson AD, Tunbridge FKE, John WG, Home PD, Alberti KGMM (1992) Diagnostic confusion in diabetes with persistence of fetal hemoglobin. Br Med J 305:635–637Google Scholar
  17. 17.
    Ryrie DR, Plowman D, Lehmann H (1977) Haemoglobin Sherwood Forest β104(G6)Arg→Thr. FEBS Lett 83:260–262PubMedGoogle Scholar
  18. 18.
    Sandhaus LM, Harvey FG (1993) Laboratory methods for the detection of hemoglobinopathies in the community hospital. Clin Lab Med 13:801–816PubMedGoogle Scholar
  19. 19.
    Schnedl WJ, Reisinger EC, Pieber TR, Lipp RW, Schreiber F, Hopmeier P, Krejs GJ (1995) Hemoglobin Sherwood Forest detected by high-performance liquid chromatography for hemoglobin A1c. Am J Clin Pathol (in press)Google Scholar
  20. 20.
    Schnedl WJ, Reisinger EC, Pieber TR, Neubauer M, Balaun E, Krejs GJ, Hopmeier P (1995) Haemoglobin Graz a novel haemoglobin variant [letter]. Diabetologia 38:122PubMedGoogle Scholar
  21. 21.
    Weykamp CW, Penders TJ, Muskiet FAJ, van der Silk W (1994) Effect of calibration on dispersion of glycohemoglobin values determined by 111 laboratories using 21 methods. Clin Chem 40:138–144PubMedGoogle Scholar
  22. 22.
    Wilkinson T, Ching GC, Carrel RW, Robin H, Exner T, Lee KM, Kronenberg H (1975) A new haemoglobin variant, haemoglobin Campertown β104(G6)arginine→ serine. Biochim Biophys Acta 393:195–200PubMedGoogle Scholar
  23. 23.
    Wong SC, Tesanovic M, Poon MC (1991) Detection of two abnormal hemoglobins, Hb Manitoba and Hb G-Coushatta, during analysis of glycohemoglobin (A1c) by high-performance liquid chromatography. Clin Chem 37:1456–1459PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • W. J. Schnedl
    • 1
  • E. C. Reisinger
    • 1
  • R. W. Lipp
    • 1
  • P. Hopmeier
    • 2
  • G. J. Krejs
    • 1
  1. 1.Department of Internal MedicineKarl Franzens UniversityGrazAustria
  2. 2.Central LaboratoryCity Hospital RudolfstiftungViennaAustria

Personalised recommendations